Connect Biopharma Hldgs Stock (NASDAQ: CNTB)

Connect Biopharma Hldgs

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACHV

ASMB

ATXI

BLBD

BRSH

CMND

CNTB

HCDI

HPCO

HRYU

ICVX

INAB

IONM

KAVL

ONTX

ORCL

SVMH

TENX

WULF

XCUR

Shares of  Icosavax, Inc.  (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Intraday Update

ADSK

AGIL

ANGH

ATGL

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATPC

EDSA

GHRS

GNTA

GSX Techedu Inc. American Depositary Shares

GOTU

GYRE

HSCS

MIRA

PXMD

RVYL

SHOT

SPRC

TCON

THAR

URBN

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

BNRG

BODY

CAPT

CYCC

NOGN

PCSA

SASI

WHLR

Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Holdings Ltd

Press Releases

Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum

Earnings

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update

Health Care

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

Management

Attovia Therapeutics Appoints Chief Financial Officer

Connect Biopharma to Present at Two Upcoming Investor Conferences

Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update

Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma

Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart

Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

Adicet Bio

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Avalo Therapeutics

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

Fortress Biotech

Forte Biosciences

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

ImmuCell

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Opus Genetics

Kronos Bio

Lantern Pharma

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

OKYO Pharma

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PepGen

PMV Pharma

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Quince Therapeutics

Renovaro

Shattuck Labs

HC Wainwright & Co.

Cantor Fitzgerald

SVB Leerink

Comments

Connect Biopharma Hldgs

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell